Kratom withdrawal treated like opioid withdrawal
We’re basically treating it as if it’s fentanyl or oxycodone or heroin
on rising kratom dependence severity
M
Myles Jen KinRecovery Centers of America · medical director
On the same topic: Biotech & medicine
More →“Novartis now expects to speak with the FDA about a potential accelerated approval of pelabresib before the end of the year, CEO Vas Narasimhan told investors on a call Tuesday.”
“The industry has gotten more consolidated. Prices are higher than ever. Access is worse than ever.”
“The rising costs are unsustainable for individuals, for businesses, and for the country. What kind of intervention is a different question.”